Cardiff Oncology vs Medicinova
Cardiff Oncology is the larger business, with $593,000 of revenue in fiscal 2025 against $409,657 for Medicinova (1.4 times as much). Cardiff Oncology grew faster (-13.2% against -59.0%). Medicinova kept more of each dollar of sales as profit: a net margin of -2928.8% against -7732.0%.
| Latest fiscal year | Cardiff OncologyCRDF, 2025 | MedicinovaMNOV, 2025 |
|---|---|---|
| Revenue | $593,000 | $409,657 |
| Revenue growth | -13.2% | -59.0% |
| Net income | −$45.9m | −$12.0m |
| Operating margin | — | -3242.5% |
| Net margin | -7732.0% | -2928.8% |
| Return on equity | -71.5% | -23.1% |
| Free cash flow | −$38.0m | −$9.8m |
| Cash | $17.5m | $30.8m |
| Total debt | $0 | $0 |
| Debt to equity | — | 0.0% |
| Dividend per share | — | — |
| Dividend yield | — | — |
| Share buybacks | — | — |
| Employees | 31 | — |
| Market value | $58.6m | $70.9m |
| Price vs our value range | — | — |
| Moat score | 5 (Weak) | — |
| Insider trades, 12 months | 4 buys, 0 sales | 0 buys, 1 sales |